Professional antigen-presenting cells—monocytes and macrophages—engulf these proteins, digest them into short peptide ...
Emerging growth opportunities in the next-generation immune checkpoint inhibitors market include the development of therapies targeting novel immune pathways employed to tackle cancer resistance ...
Phase 2 study to evaluate combination therapy in patients with metastatic colorectal cancer, targeting β-catenin-driven immune exclusion in liver ...
ICIs combined with chemotherapy showed higher efficacy than bevacizumab in treating advanced driver gene–negative NS-NSCLC. The study reported improved PFS and OS for patients receiving ICIs compared ...
New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...
Morning Overview on MSN
The two drugs that just cleared Alzheimer’s plaques in mice already sit in pharmacies as cancer treatments — a shortcut that could reach patients years sooner
In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...
Immunotherapies such as so-called checkpoint inhibitors activate the body's own immune system to fight cancer cells and have ...
For the past 15 years or so, a class of drugs called immune checkpoint inhibitors have been used to treat melanoma – the most ...
A recent study found that monthly prices of checkpoint inhibitors decreased only slightly from 2015 to 2024, with declines in annual average sales prices ranging from 0.21% to 4.85%. "Prices of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results